Evaluating Neem (Azadirachta indica) Extracts as Alternative Bactericidal Agents Against Antibiotic-Resistant Pathogens
Abstract
The rise of multidrug-resistant (MDR) pathogens threatens global health, prompting the search for alternative antimicrobials. This study evaluated the bactericidal activity of Azadirachta indica (neem) leaf extracts against clinical strains of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus. The leaves were authenticated, air-dried, and extracted using ethanol and water via cold maceration and Soxhlet extraction methods. Bacterial identity was confirmed with standard microbiological tests and subjected to antibiotic susceptibility testing using the disk diffusion method. The neem extract was analysed using a Shimadzu GC-MS-QP 2010 Plus system, and its antimicrobial activity was evaluated using the agar diffusion and broth microdilution methods. Antibiotic susceptibility showed high resistance to amoxicillin and ciprofloxacin, while meropenem was most effective. Hot ethanol extracts exhibited the strongest antibacterial activity, with inhibition zones up to 22.0 ± 1.4 mm for E. coli, and MIC/MBC assays confirmed bactericidal effects. Time–kill studies demonstrated complete elimination within 12–24 hours. GC-MS profiling revealed dominant compounds including n-hexadecanoic acid (19.8%), phytol (9.2%), and 9,12,15-octadecatriene-1-ol (8.1%). These results underscore the effectiveness of neem as a natural antibacterial agent and highlight its potential as a complementary or alternative therapy against antibiotic resistant pathogens.